There were very close correlations in fracture probabilities between the surrogate and authentic models (r ≥ 0.998) so that the use of the Pakistan model had little impact on the rank order of risk. It was estimated that 36,524 hip fractures arose in 2015 in individuals over the age of 50 years in Pakistan, with a predicted increase by 214% to 114,820 in 2050. The surrogate FRAX model for Pakistan provides an opportunity to determine fracture probability within the Pakistan population and help guide decisions about treatment.The surrogate FRAX model for Pakistan provides an opportunity to determine fracture probability within the Pakistan population and help guide decisions about treatment. Despite its history as one of the most impactful toxicities associated with cytotoxic cancer therapy, oral mucositis (OM) remains an unmet clinical need which affects hundreds of thousands of patients. Descriptions of its complex pathogenesis have provided mechanistic targets which are being exploited to develop an effective therapeutic intervention. Favorable results of recently completed clinical trials in which agents focused on interrupting the early stages of the mucositis biological cascade were assessed provide reason for optimism, not only for oral mucositis but also for halo indications which share its pathobiogenesis.Despite its history as one of the most impactful toxicities associated with cytotoxic cancer therapy, oral mucositis (OM) remains an unmet clinical need which affects hundreds of thousands of patients. Descriptions of its complex pathogenesis have provided mechanistic targets which are being exploited to develop an effective therapeutic intervention. Favorable results of recently completed clinical trials in which agents focused on interrupting the early stages of the mucositis biological cascade were assessed provide reason for optimism, not only for oral mucositis but also for halo indications which share its pathobiogenesis.The ESR International Forum at the ECR 2020 discussed the current situation, activities and measures undertaken by radiologists around the world in their fight against the global COVID-19 pandemic. The participating societies were invited to submit written reports detailing the current situation in their countries or regions. The European Society of Radiology (ESR) established the ESR International Forum in order to discuss hot topics in the profession of radiology with non-European radiological partner societies. At the ESR International Forum 2020, different strategies, initiatives, and ideas were presented with regard to facing this unprecedented challenge together.The current review critically analyzes obesity as an important risk factor for increased predisposition towards coronavirus disease 2019 (COVID-19), its severity and causal death in current pandemic. Countries with higher prevalence of exposed obese individuals experienced the highest number of mortalities. VVD-130037 supplier The analysis also proved that individuals having more adipose tissue in body have a higher level of angiotensin-converting enzyme 2 (ACE2), which is identified as functional receptor for COVID-19. Therefore, obese individuals are worse in condition because of a higher presence of adiposity increases the number of ACE2 expressing cells. Furthermore, in silico interactions of ACE2 and different variants of coronavirus 2 (CoV-2) spike S1 protein suggest that mutant strains are more infectious than wildtype as they bind to host ACE2 protein with high binding affinities. Certain specific cancers including cervical cancer, pancreatic and rectal adenocarcinomas have more expression of such receptors and pose additional risk to already immunocompromised cancer patients. This review emphasizes obesity, as the covert risk factor of COVID-19 infection and sensitizes about of calorie restrictions, immunity building and preventive measures.Cardiovascular diseases have consistently been one of the leading causes of mortality, despite investigations by many scientists and clinicians. Animal models are versatile platforms to illustrate various mechanisms of different diseases, but are lacking in accurately portraying cardiovascular disease phenotypes. The advent of human pluripotent stem cells (PSCs) has led to much development in the construction of cardiovascular disease models. In this review, we provide a brief overview of the history and utilization of PSCs for cardiovascular precision medicine, including disease modeling, drug screening, and gene editing, and elaborate on the current updated research status of patient-specific induced pluripotent stem cell (iPSC)-based disease models for cardiac channelopathies, cardiomyopathies, and other cardiovascular diseases. Furthermore, we highlight the development of novel human iPSC-derived engineered heart tissues for cardiovascular disease modeling. Finally, we put forward our own views on the existing advantages and difficulties for moving forward in this field.The objective of the present study was to evaluate the viability of a mycotoxin adsorbent based on beta-glucans from cell walls of Saccharomyces cerevisiae and bentonites in the diets of confined lambs of the Texel breed. Twenty-four lambs (12 males and 12 females) with an average weight of 18.6 kg ± 1.6 were divided into two groups treated (with adsorbent) and control. The animal diets contained the mycotoxins aflatoxin B1, fumonisin B1 and B2, zearalenone, and deoxynivalenol in concentrations within guidance levels. The animals were slaughtered with body weight of approximately 26.4 kg. The performance and carcass variables of the lambs were evaluated. The daily weight gain was higher in the treated group (216.24 g) than in the control group (185.90 g). The averages for loin eye area, subcutaneous fat thickness, and marbling were 13.93 cm2, 2.66 mm, and 3.20 in the treated group and 12.16 cm2, 2.6 mm, and 3.25 in the control group, respectively. The true, hot, and cold carcass yield, and the carcass cooling losses did not differ between groups. The carcasses were similar in conformation and fat finishing degree, with averages of 3.95 and 3.83, respectively. To the best of our knowledge, this is the first study to evaluate the effect of a mycotoxin additive in the diet of finishing lambs. The use of mycotoxin adsorbent in confined lambs was feasible, and its use resulted in greater daily weight gain in lambs and average net profit.